Role of Growth Hormone/Insulin-Like Growth Factor-1 Axis Dysfunction and Inflammatory Cytokines in Pediatric Short Stature:

Qingfu  Yang; Shanshan  Chen; Tieniu  Wu; Jingxin  Peng; Lidan  Mao

doi:10.5937/jomb0-57933

Qingfu Yang Department of Pediatrics, Ganzhou Maternal and Child Health Hospital, 25 Nankang Road, Zhanggong District, Ganzhou City, Jiangxi Province, 341000, China
Shanshan Chen Department of Pediatrics, The Affiliated Yangming Hospital of Ningbo University(YuYao People's Hospital), No. 800 Chengdong Road, Yuyao City, Zhejiang Province, 315400, China
Tieniu Wu Department of Pediatrics, Ganzhou Maternal and Child Health Hospital, 25 Nankang Road, Zhanggong District, Ganzhou City, Jiangxi Province, 341000, China
Jingxin Peng Department of Pediatrics, Ganzhou Maternal and Child Health Hospital, 25 Nankang Road, Zhanggong District, Ganzhou City, Jiangxi Province, 341000, China
Lidan Mao The Affiliated Yangming Hospital of Ningbo University (YuYao People's Hospital), Department of Paediatrics, Yuyao City, Zhejiang Province, China

DOI: https://doi.org/10.5937/jomb0-57933

Keywords: Pediatric short stature, GH/IGF-1 axis, inflammatory cytokines, interleukin-6, interleukin-8, genetic mutations, growth hormone receptor

Abstract

Background: Pediatric short stature is a prevalent clinical issue, often linked to dysfunction in the growth hormone/insulin-like growth factor-1 (GH/IGF-1) axis. Recent research suggests that inflammatory cytokines and serum markers may play a role in this dysfunction. This study aims to explore the molecular mechanisms contributing to GH/IGF-1 axis dysfunction, along with the levels of inflammatory cytokines and other relevant markers in children with short stature.

Methods: 150 children diagnosed with short stature (defined as height below the 3rd percentile for age and sex) were recruited from the endocrinology ward of a tertiary care hospital. A control group of 150 age- and sex-matched healthy children was included for comparison. Serum levels of GH, IGF-1, interleukin-6 (IL-6), interleukin-8 (IL-8), and other relevant markers were measured using enzyme-linked immunosorbent assay (ELISA). Genetic analysis was performed to identify potential mutations in GH/IGF-1 axis-related genes. Data were analyzed using SPSS software, with statistical significance set at p < 0.05.

Results: Children with short stature exhibited significantly lower serum levels of GH and IGF-1 compared to controls (p < 0.001). Elevated levels of IL-6 and IL-8 were found in the short stature group (p < 0.01). Genetic analysis revealed a higher frequency of mutations in the growth hormone receptor (GHR) gene in the short stature cohort. Correlation analysis showed a negative association between serum IL-6 levels and IGF-1 levels (r = -0.45, p < 0.001).

Conclusion: This study provides evidence that dysfunction in the GH/IGF-1 axis, along with elevated inflammatory cytokines, may contribute to the pathogenesis of pediatric short stature. Further research is needed to investigate potential therapeutic targets and interventions aimed at addressing these molecular mechanisms.

References

1. Polidori N, Castorani V, Mohn A, Chiarelli F. Deciphering short stature in children. Ann Pediatr Endocrinol Metab. 2020;25(2):69-79.
2. Haymond M, Kappelgaard AM, Czernichow P, Biller BM, Takano K, Kiess W. Early recognition of growth abnormalities permitting early intervention. Acta Paediatr. 2013;102(8):787-96.
3. Barstow C, Rerucha C. Evaluation of Short and Tall Stature in Children. Am Fam Physician. 2015;92(1):43-50.
4. Blum WF, Alherbish A, Alsagheir A, El Awwa A, Kaplan W, Koledova E, et al. The growth hormone-insulin-like growth factor-I axis in the diagnosis and treatment of growth disorders. Endocr Connect. 2018;7(6):R212-r22.
5. Al-Samerria S, Radovick S. The Role of Insulin-like Growth Factor-1 (IGF-1) in the Control of Neuroendocrine Regulation of Growth. Cells. 2021;10(10).
6. Wydra A, Czajka-Oraniec I, Wydra J, Zgliczyński W. The influence of growth hormone deficiency on bone health and metabolisms. Reumatologia. 2023;61(4):239-47.
7. Witkowska-Sędek E, Pyrżak B. Chronic inflammation and the growth hormone/insulin-like growth factor-1 axis. Cent Eur J Immunol. 2020;45(4):469-75.
8. Hirano T. IL-6 in inflammation, autoimmunity and cancer. Int Immunol. 2021;33(3):127-48.
9. Bernhard S, Hug S, Stratmann AEP, Erber M, Vidoni L, Knapp CL, et al. Interleukin 8 Elicits Rapid Physiological Changes in Neutrophils That Are Altered by Inflammatory Conditions. J Innate Immun. 2021;13(4):225-41.
10. Bakker AD, Jaspers RT. IL-6 and IGF-1 Signaling Within and Between Muscle and Bone: How Important is the mTOR Pathway for Bone Metabolism? Curr Osteoporos Rep. 2015;13(3):131-9.
11. Savage MO, Hwa V, David A, Rosenfeld RG, Metherell LA. Genetic Defects in the Growth Hormone-IGF-I Axis Causing Growth Hormone Insensitivity and Impaired Linear Growth. Front Endocrinol (Lausanne). 2011;2:95.
12. Chen JY, Griffiths M, Yang J, Nies MK, Damico RL, Simpson CE, et al. Elevated Interleukin-6 Levels Predict Clinical Worsening in Pediatric Pulmonary Arterial Hypertension. J Pediatr. 2020;223:164-9.e1.
13. Blanchard F, Duplomb L, Baud'huin M, Brounais B. The dual role of IL-6-type cytokines on bone remodeling and bone tumors. Cytokine Growth Factor Rev. 2009;20(1):19-28.
14. Bartke A, Brown-Borg H. Mutations Affecting Mammalian Aging: GH and GHR vs IGF-1 and Insulin. Front Genet. 2021;12:667355.
15. Cirillo F, Lazzeroni P, Sartori C, Street ME. Inflammatory Diseases and Growth: Effects on the GH-IGF Axis and on Growth Plate. Int J Mol Sci. 2017;18(9).
16. DeBoer MD, Scharf RJ, Leite AM, Férrer A, Havt A, Pinkerton R, et al. Systemic inflammation, growth factors, and linear growth in the setting of infection and malnutrition. Nutrition. 2017;33:248-53.
17. Hwa V, Fujimoto M, Zhu G, Gao W, Foley C, Kumbaji M, et al. Genetic causes of growth hormone insensitivity beyond GHR. Rev Endocr Metab Disord. 2021;22(1):43-58.